NCT01466361View on ClinicalTrials.gov

Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving

PHASE2CompletedINTERVENTIONAL

Enrollment

187

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

SmokingSmoking Cessation

Interventions

DRUG

Nicotine lower dose

lower dose nicotine lozenge

DRUG

Nicotine higher dose

higher dose nicotine lozenge

DRUG

Placebo

placebo

Trial Locations (1)

91505

Los Angeles Clinical Trials, Burbank

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01466361 - Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving | Biotech Hunter | Biotech Hunter